ClinicalTrials.gg
CompletedNCT00610402Updated Oct 20, 2022

Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)

An observational study in Sturge - Weber Syndrome (SWS), sponsored by University of California, Irvine. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2022-10-20.

Sponsored by University of California, Irvine · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
57
Sex
All
01

Study summary

Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life.

Glaucoma represents a group of ocular disorders that are characterized by the loss of retinal ganglion cells and their axons, damage to the optic nerve, and gradual loss of visual field. Recently, several studies provided evidence that there is a potential role of the immune system in the pathogenesis of glaucoma.

These findings suggest that there might be changes in systemic humoral immunity possibly underlying the optic neuropathy in at least some glaucoma patients.

Read the detailed description

The ocular antibody profile in patients with SWS is unknown.The researchers want to study on blood and tear drop samples from patients with SWS to determine the incidence of ocular antibodies in patients with this syndrome.

02

Conditions studied

  • Sturge - Weber Syndrome (SWS)

Browse trials for

03

In context

Brain Stem Infarctions

42 studies on the registry are indexed under Brain Stem Infarctions; 20 are open to participants now.

Browse Brain Stem Infarctions studies →

Lead sponsor

University of California, Irvine is the lead sponsor of 474 studies on the registry; 96 are open to participants now.

Of its 41 completed or terminated interventional studies of FDA-regulated products, 30 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

community sample

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female volunteers with SWS of all ages

Exclusion criteria

Exclusion Criteria:

  • Volunteers without SWS
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
57 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • blood sample tear drop sample

    blood sample tear drop sample

    Other: blood sample tear drop sample

Interventions

  • Otherblood sample tear drop sample

    blood sample tear drop sample

06

Study locations

1 site
  • Beckman Laser Institute Medical clinic
    Irvine, California 92612, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00610402
Collaborators
Mainz University
Responsible party
Beckman Laser Institute and Medical Center (J.S.Nelson, MD,PhD,Professor of Surgery and Biomedical Engineering, University of California, Irvine) — Principal investigator
First posted
Feb 8, 2008
Start date
Jul 2007
Primary completion
Jul 2007
Completion
Jun 2008
Last update
Oct 20, 2022

Study contacts

John S Nelson, M.D,PhD
principal investigator · Beckman Laser Institute University of California Irvine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion